Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RX
- Prescription Medicines
N-DICLOFENAC 50 mg
Non-steroidal anti-inflammatory drug with strong analgesic (pain-relieving) and antipyretic (fever-reducing) effect
Coated tablets
50 mg
NIMESULIDA ARENA 100 mg
Selective non-steroidal anti-inflammatory drug, with analgesic and antipyretic effect
Tablets
100 mg
NITROFURANTOINA ARENA100 mg
Antimicrobial drug indicated in the treatment and prophylaxis of urinary tract infections
Tablets
100 mg
NORFLOXACINA ARENA 400 mg
Fluoroquinolone antibiotic, indicated in urinary tract infections
Capsules
400 mg
OLANZAPINA ARENA 10 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and bipolar disorder
Film-coated tablets
10 mg
OLANZAPINA ARENA 15 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and bipolar disorder
Film-coated tablets
15 mg
OLANZAPINA ARENA 2.5 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and bipolar disorder
Film-coated tablets
2.5 mg
OLANZAPINA ARENA 5 mg
Atypical antipsychotic drug indicated in the treatment of schizophrenia and bipolar disorder
Film-coated tablets
5 mg
OMEPRAZOL ARENA 20 mg
Proton pump inhibitor, indicated in the treatment of gastroduodenal ulcer and gastroesophageal reflux
Gastro-resistant capsules
20 mg